Latest News

Fourth-generation MitraClip receives FDA approval

According to a statement, Abbott has announced it has received US Food and Drug Administration (FDA) approval for the fourth-generation MitraClip heart valve repair...

Women with idiopathic intracranial hypertension at twice the risk of cardiovascular...

SAVR has lower mortality and MACCE than TAVI using first-generation devices...

Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

Medtronic announces global registry of HVAD thoracotomy implants

Features

The influence of technology and robotics in the catheterisation laboratory is...

Thanks to the use of robotics in healthcare, many procedures that were once highly invasive are now being performed using minimally invasive techniques, with...

New Liverpool Centre for Cardiovascular Science established

The Liverpool Centre for Cardiovascular Science, an alliance between academia and the NHS, was established to advance cardiovascular and stroke research and innovation locally,...

Videos

TRILUMINATE trial shows “extremely favourable” results in patients with tricuspid regurgitation

Speaking to Cardiovascular News at EuroPCR 2019 (21–24 May, Paris, France), Georg Nickenig (Bonn, Germany), discusses the results of the TRILUMINATE trial which looked at the safety and efficacy of treating tricuspid regurgitation with a novel tricuspid valve repair...

Events

Adrian Banning

Robert W Yeh

Olaf Wendler

(Visited 41,610 times, 7 visits today)
Cardiovascular News

Write to us
Editor: Dawn Powell dawn@bibamedical.com
Advertising: Elizabeth Sutherst elizabeth@bibamedical.com

BIBA Medical Ltd, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 EMAIL: info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.

Terms and Conditions | Privacy Policy